Literature DB >> 7825225

The epidemiology, immunology and morbidity of Schistosoma haematobium infections in diverse communities in Zimbabwe. I. The study design.

P Hagan1, S Chandiwana, P Ndhlovu, M Woolhouse, A Dessein.   

Abstract

Recent studies on the immunology and epidemiology of Schistosoma haematobium infection have led to several new hypotheses regarding the relationships between the transmission of infection and the development of resistance to infection and also the associations between particular antibody and cellular reactivities with resistance or susceptibility to reinfection after chemotherapy. The study will extend the information on the development of protective immune responses during Schistosoma haematobium infection by examining these responses in groups of children and adults from areas in which differences in the peak prevalence of infection have been reported. Our working hypothesis is that, in areas of intense transmission, resistance to infection develops sooner than in areas where transmission is not so intense. We will investigate whether or not this is the case by monitoring levels of reinfection after chemotherapy and by trying to relate observed resistance and susceptibility to reinfection to serological and cellular reactivities. Exposure to infection, cercariometry and malacological studies will also be completed in both areas. The possibility that resistance to infection is associated with T lymphocyte responses classed as Th-2 type will be investigated by assessing reactivities to defined antigens of S. haematobium. This study will generate data which will be used to develop and test mathematical models of the epidemiological determinants which are important in human schistosomiasis.

Entities:  

Mesh:

Year:  1994        PMID: 7825225

Source DB:  PubMed          Journal:  Trop Geogr Med        ISSN: 0041-3232


  4 in total

1.  Enhancing schistosomiasis control strategy for zimbabwe: building on past experiences.

Authors:  Moses J Chimbari
Journal:  J Parasitol Res       Date:  2012-05-08

2.  Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries.

Authors:  Amara E Ezeamama; Chun-La He; Ye Shen; Xiao-Ping Yin; Sue C Binder; Carl H Campbell; Stephen Rathbun; Christopher C Whalen; Eliézer K N'Goran; Jürg Utzinger; Annette Olsen; Pascal Magnussen; Safari Kinung'hi; Alan Fenwick; Anna Phillips; Josefo Ferro; Diana M S Karanja; Pauline N M Mwinzi; Susan Montgomery; W Evan Secor; Amina Hamidou; Amadou Garba; Charles H King; Daniel G Colley
Journal:  BMC Infect Dis       Date:  2016-05-26       Impact factor: 3.090

3.  Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.

Authors:  Anna E Phillips; Pedro H Gazzinelli-Guimaraes; Herminio O Aurelio; Josefo Ferro; Rassul Nala; Michelle Clements; Charles H King; Alan Fenwick; Fiona M Fleming; Neerav Dhanani
Journal:  PLoS Negl Trop Dis       Date:  2017-12-08

4.  Evaluating the impact of biannual school-based and community-wide treatment on urogenital schistosomiasis in Niger.

Authors:  Anna E Phillips; Zilahatou Tohon; Neerav A Dhanani; Boubacar Sofo; Issa Gnandou; Boubacar Sidikou; Adamou Garba Noma; Bassirou Madougou; Oumarou Alto; Hannatou Sebangou; Kader M Halilou; Roumanatou Andia; Amadou Garba; Alan Fenwick; Amina A Hamidou
Journal:  Parasit Vectors       Date:  2020-11-18       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.